ALLMedicine™ Acute Pyelonephritis Center
Research & Reviews 251 results
European Journal of Radiology; Marron D, Nahum GS et. al.
Aug 3rd, 2021 - To determine whether contrast enhanced DECT low monoenergetic can improve diagnostic conspicuity of inflamed kidney foci in acute pyelonephritis compared to conventional images. A retrospective study of 45 patients with clinical signs of acute pye...
Urology Patel H, Shekar P A et. al.
Jul 25th, 2021 - Acute Lobar Nephronia (ALN) is a rare infective condition of the kidney currently described only in case reports and small case series. The diagnosis of ALN is made by characteristic clinico-radiological findings. Differentiation from acute pyelon...
American Family Physician;
Jul 16th, 2021 - Heavy Menstrual Bleeding, Acute Pyelonephritis, Bacteriuria, IgA Vasculitis, Febrile UTIs.|2021||
BMJ Case Reports; Yoshiyama N, Uzu H et. al.
Jul 15th, 2021 - Acute pyelonephritis after recovery from heat stroke.|2021|Yoshiyama N,Uzu H,Ito T,Ogura S,|complications,
BMC Pediatrics; Peñalver Penedo R, Rupérez Lucas M et. al.
Jul 1st, 2021 - Midregional-proadrenomedullin (MR-proADM) is a useful prognostic peptide in severe infectious pathologies in the adult population. However, there are no studies that analyze its utility in febrile urinary tract infection (fUTI) in children. An acc...
Guidelines 1 results
Journal of the American College of Radiology : JACR; , Nikolaidis P et. al.
Nov 6th, 2018 - Pyelonephritis refers to infection involving the renal parenchyma and renal pelvis. In most patients, uncomplicated pyelonephritis is diagnosed clinically and responds quickly to appropriate antibiotic treatment. If treatment is delayed, the patie...
Drugs 65 results see all →
Clinicaltrials.gov 16 results
Oct 16th, 2018 - This was a Phase 3 study containing a randomized open-label superiority cohort (Cohort 1) comparing the efficacy and safety of plazomicin with colistin when combined with a second antibiotic (either meropenem or tigecycline) in the treatment of pa...
Sep 21st, 2018 - Phase 2, randomised, double-blind, 2-cohort study in hospitalised adults with complicated urinary tract infection (cUTI), including acute pyelonephritis. All study cohorts were randomised in a 2:1 ratio. Treatment duration for each cohort was 7 to...
Aug 23rd, 2018 - This was a randomized, multicenter, multinational, double-blind study comparing the efficacy and safety of plazomicin compared with meropenem followed by optional oral (PO) therapy in the treatment of cUTI, including AP, in adults.
Aug 22nd, 2018 - This was a multi-center, multi-national, double-blind, randomized, comparator-controlled study of plazomicin administered intravenously compared with levofloxacin, a standard approved intravenous therapy for complicated urinary tract infection (cU...
Jun 14th, 2018 - This study is a double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy of IV ETX2514SUL in patients with cUTIs who are otherwise relatively healthy. Patients with Acute Pyelonephritis may also be enrolled. Approxima...
News 15 results
Oct 30th, 2020 - A new formulation of an existing antibacterial agent and a potential therapeutic approach to a challenging clinical problem were the focus of a session on potentially practice-changing clinical trials in antimicrobial therapy presented during IDWe...
Feb 20th, 2019 - Intravenous plazomicin was non-inferior to meropenem for the treatment of complicated urinary tract infections (UTIs), including acute pyelonephritis, a randomized trial found. Composite cure was achieved in 88.0% of patients in the plazomicin gro...
Infectious Disease Practitioner; Jim Kling
Oct 29th, 2018 - SAN FRANCISCO – A combination of ceftriaxone, a beta-lactamase inhibitor, and disodium ethylenediaminetetraacetic acid (EDTA) is superior to meropenem in the treatment of complicated urinary tract infections caused by extended-spectrum beta-lactam.
Oct 18th, 2018 - I often find myself under- or overestimating the incidence of certain nephrology-related conditions. I know this "error" is, in part, due to an "exposure bias" in my practice. I tend to overestimate the incidence of conditions I commonly see and u...
Feb 27th, 2018 - Action Points Meropenem-vaborbactam, a combination medication for certain types of drug-resistant infections, was comparable to piperacillin-tazobactam, for treating complicated urinary tract infections (UTI). Note that the portion of patients who...